Yong-Qiu Mao

1.3k citations
50 papers · 1.1k indexed · h-index 20
Topics
RNA Interference and Gene Delivery (10 papers)Cell death mechanisms and regulation (10 papers)Immunotherapy and Immune Responses (9 papers)
Partner nations
ChinaEthiopiaIreland

In The Last Decade

Yong-Qiu Mao

49 papers receiving 1.1k citations

Peers

Yong-Qiu Mao
Comparison fields: 5 of 102
  • Molecular Biology 596
  • Oncology 213
  • Immunology 205
  • Cancer Research 177
  • Organic Chemistry 148
Replace Céline Loncle with:
Céline Loncle France
Anabel Sorolla Spain
Dana Cholujová Slovakia
Fernando Rodríguez‐Serrano Spain
Oliver Plettenburg Germany
Nickolai A. Barlev Russia
Na Luo China
José Sullivan López-González Mexico
Jichuang Wang China
Jean‐Pierre Gillet United States
Yong-Qiu Mao relative to Céline Loncle France Céline Loncle's profile →
Citations per field
00.5×1.5×
Céline Loncle · 1×
Citations per year

Countries citing papers authored by Yong-Qiu Mao

Since Specialization
Citations

This map shows the geographic impact of Yong-Qiu Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong-Qiu Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong-Qiu Mao more than expected).

Fields of papers citing papers by Yong-Qiu Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong-Qiu Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong-Qiu Mao. The network helps show where Yong-Qiu Mao may publish in the future.

Co-authorship network of co-authors of Yong-Qiu Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Yong-Qiu Mao. A scholar is included among the top collaborators of Yong-Qiu Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong-Qiu Mao. Yong-Qiu Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 89
2 18
3 19
4 23
5 63
6 14
7 6
8 49
9 3
10 3
11 78
12 14
13 26
14 42
15 3
16 63
17 25
18 35
19 55
20 71

About Yong-Qiu Mao

Yong-Qiu Mao is a scholar working on Toxicology, Biotechnology and Immunology, having authored 50 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (10 papers), Cell death mechanisms and regulation (10 papers) and Immunotherapy and Immune Responses (9 papers). The work is most often cited by research in Toxicology (49 citations), Cancer Research (177 citations) and Immunology (205 citations). Yong-Qiu Mao has collaborated with scholars based in China, Ethiopia and Ireland. Frequent co-authors include Yuquan Wei, Yinglan Zhao, Zhengguang Li, Peidu Jiang, Yuzhu Zheng, Xia Zhao, Lijuan Chen, Yang Li, Shengyong Yang and Hongxin Deng. Their work appears in journals such as The Journal of Immunology, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026